Home- vs. mobile clinic-based HIV testing and counseling in rural Africa

December 16, 2014

Home- and community-based HIV testing and counselling services can achieve high participation uptake in rural Africa but reach different populations within a community and should be provided depending on the groups that are being targeted, according to new research published in this week's PLOS Medicine by Niklaus Labhardt from the Swiss Tropical and Public Health Institute, and colleagues from SolidarMed, a Swiss non-governmental Organization for Health in Africa.

Annually, about 2.3 million people become newly infected with HIV, the virus that causes AIDS. A key step in receiving treatment for HIV and reducing further transmission of the virus is receiving HIV testing and counselling, but in countries where HIV is prevalent, such as many parts of rural Africa, access to these services can be limited by resources or because people fear stigmatization and discrimination. One option to improve HIV testing and counselling coverage is to provide this service to individuals in a community setting as part of a campaign that provides multiple health services (for example, family planning, TB screening and blood-pressure measurement) instead of relying on individuals visiting health facilities to be tested. However, the evidence base for how to deliver these services to test different populations is poor.

In a cluster randomized controlled trial in rural Lesotho the authors tested two different community approaches for delivering the same HIV testing and counselling services; in one individuals were offered the services in their homes, and in another services were offered at a mobile clinic that was set up at a community gathering. The study included 2563 participants and the authors found that uptake of HIV testing and counselling was higher for those offered home-based services compared to services at the mobile clinic (92.5% and 86.7%, respectively). By analysing this outcome by age the authors noted that there was a large difference in uptake among children <12 years old because the child's caretakers were more likely to agree to HIV-testing in the home-based group. The authors also found that while more individuals tested positive in the mobile clinic setting (6.2% vs 3.6% in the home-based setting), the home-based approach reached more first-time testers (particularly among adolescents) and tended to reach more men.

The authors conclude, "[o]verall, both study groups achieved a high uptake of [HIV testing and counselling], endorsing the use of community-based multi-disease approaches to reach populations that may not access facility-based [HIV testing and counselling]. Based on our results, the choice between [home-based versus mobile clinic approaches] should be guided by the intervention's objective."

However, the authors also noted that improving treatment coverage depends on the testing approaches being combined with effective interventions to improve linkage to care; only one in four individuals who tested positive for HIV in either study group was successfully enrolled in care at local health facilities within 1 month of testing positive for HIV.
-end-
Research Article

Funding: The trial was part of the SolidarMed ART-project in Lesotho (SMART 3). Except the salary of the nurses of the study-team who were employees of the

Ministry of Health of Lesotho or the Christian Health Association of Lesotho (CHAL), all other costs to implement the study (as listed in Table S1) were covered by the SolidarMed project cost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: : Labhardt ND, Masetsibi M, Cerutti B, Pfeiffer K, Kamele M, et al. (2014) Home-Based Versus Mobile Clinic HIV Testing and Counseling in Rural Lesotho: A Cluster-Randomized Trial. PLoS Med 11(12): e1001768. doi:10.1371/journal.pmed.1001768

Author Affiliations:
Swiss Tropical and Public Health Institute, University of Basel, SWITZERLAND
SolidarMed Lesotho, Seboche Hospital, LESOTHO
University of Geneva, SWITZERLAND
SolidarMed Lesotho, Paray Hospital, LESOTHO

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001768

Contact:
Niklaus Labhardt
Swiss Tropical and Public Health Institute
University of Basel
SWITZERLAND
+4179 870 18 59
n.labhardt@unibas.ch; niklaus.labhardt@gmail.com


PLOS

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.